These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 758251)

  • 21. Antipsychotic prescribing patterns and the treatment of extrapyramidal symptoms in older people.
    Kalish SC; Bohn RL; Mogun H; Glynn RJ; Gurwitz JH; Avorn J
    J Am Geriatr Soc; 1995 Sep; 43(9):967-73. PubMed ID: 7657936
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Abuse of the antiparkinson drugs: a review of the literature.
    Smith JM
    J Clin Psychiatry; 1980 Oct; 41(10):351-4. PubMed ID: 7430078
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacological treatment of substance-abusing schizophrenic patients.
    Siris SG
    Schizophr Bull; 1990; 16(1):111-22. PubMed ID: 1970669
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Antiparkinsonian drugs].
    Rascol A; Montastruc JL; Rascol O
    Rev Prat; 1989 Mar; 39(8):663-9. PubMed ID: 2567051
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of the antiparkinsonian drug budipine on neurotransmitter release in central nervous system tissue in vitro.
    Jackisch R; Huang HY; Reimann W; Limberger N
    J Pharmacol Exp Ther; 1993 Feb; 264(2):889-98. PubMed ID: 8094757
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Educational approaches to prescribing practices and substance abuse.
    Chappel JN
    J Psychoactive Drugs; 1991; 23(4):359-63. PubMed ID: 1813608
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Where Is Buprenorphine Dispensed to Treat Opioid Use Disorders? The Role of Private Offices, Opioid Treatment Programs, and Substance Abuse Treatment Facilities in Urban and Rural Counties.
    Stein BD; Pacula RL; Gordon AJ; Burns RM; Leslie DL; Sorbero MJ; Bauhoff S; Mandell TW; Dick AW
    Milbank Q; 2015 Sep; 93(3):561-83. PubMed ID: 26350930
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antiparkinsonian drugs: pharmacological and therapeutic aspects.
    Calne DB; Reid JL
    Drugs; 1972; 4(1):49-74. PubMed ID: 4405376
    [No Abstract]   [Full Text] [Related]  

  • 29. Prescription drug abuse.
    Finch J
    Prim Care; 1993 Mar; 20(1):231-9. PubMed ID: 8464944
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Letter: Interaction between antiparkinsonian drugs and neuroleptics.
    Marriott PF
    Am J Psychiatry; 1975 Nov; 132(11):1224. PubMed ID: 1166909
    [No Abstract]   [Full Text] [Related]  

  • 31. Carisoprodol (soma): abuse potential and physician unawareness.
    Reeves RR; Carter OS; Pinkofsky HB; Struve FA; Bennett DM
    J Addict Dis; 1999; 18(2):51-6. PubMed ID: 10334375
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The rate, pattern, and cost of use of antiparkinsonian agents among patients treated for schizophrenia in a managed care setting.
    Ascher-Svanum H; Kennedy JS; Lee D; Haberman M
    Am J Manag Care; 2004 Jan; 10(1):20-4. PubMed ID: 14738183
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Non-medical use and abuse of commonly prescribed medications.
    Riggs P
    Curr Med Res Opin; 2008 Mar; 24(3):869-77. PubMed ID: 18267053
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Letter: Dependence on antiparkinsonian drugs.
    Marriott P
    Br Med J; 1976 Jan; 1(6002):152. PubMed ID: 1247752
    [No Abstract]   [Full Text] [Related]  

  • 35. Searching for answers: proper prescribing of controlled prescription drugs.
    Brown ME; Swiggart WH; Dewey CM; Ghulyan MV
    J Psychoactive Drugs; 2012; 44(1):79-85. PubMed ID: 22641969
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of anticholinergic-antiparkinsonian drugs on striatal neurotransmitter levels of rats intoxicated with soman.
    Shih TM; Capacio BR; Cook LA
    Pharmacol Biochem Behav; 1993 Mar; 44(3):615-22. PubMed ID: 8095723
    [TBL] [Abstract][Full Text] [Related]  

  • 37. AMA 1981 annual meeting report. Drug abuse related to prescribing practices.
    J Tenn Med Assoc; 1981; 75(3):199-200. PubMed ID: 7343784
    [No Abstract]   [Full Text] [Related]  

  • 38. Interactions of some cholinolytic anti-parkinson drugs with nicotine and oxotremorine on rat diaphragm.
    Das M; Ganguly DK
    Toxicol Appl Pharmacol; 1977 Jan; 39(1):149-52. PubMed ID: 190736
    [No Abstract]   [Full Text] [Related]  

  • 39. Influences of an anticholinergic antiparkinsonian drug, parkinsonism, and psychotic symptoms on cardiac autonomic function in schizophrenia.
    Okada T; Toichi M; Sakihama M
    J Clin Psychopharmacol; 2003 Oct; 23(5):441-7. PubMed ID: 14520119
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Drug abuse related to prescribing practices.
    JAMA; 1982 Feb; 247(6):864-6. PubMed ID: 7057570
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.